Sunnyvale, CA, United States of America

Birgitt Schüle

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2014)
  • Sunnyvale, CA (US) (2015 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Birgitt Schüle: Innovator in Genetic Research

Introduction

Birgitt Schüle is a prominent inventor based in Sunnyvale, CA, known for her significant contributions to genetic research. With a total of 4 patents, she has made remarkable strides in the field of biotechnology, particularly in the study of human cells and Parkinson's disease.

Latest Patents

One of her latest patents focuses on the site-specific integration of transgenes into human cells. This patent provides methods for inserting a polynucleotide sequence into the genome of a human cell, resulting in the insertion of a sequence of interest into the H11 locus. Additionally, it includes nucleic acids that facilitate this integration and describes a transgenic human cell featuring site-specific recombination sites at the H11 locus. Another notable patent addresses an assay to determine LRRK2 activity in Parkinson's disease. This patent discloses novel phosphorylation sites identified in LRRK2, which are associated with Parkinson's Disease, along with antibodies that specifically bind to these sites for laboratory and clinical applications.

Career Highlights

Birgitt Schüle has worked with esteemed institutions such as the Parkinson's Institute and Leland Stanford Junior University. Her work has significantly advanced the understanding of genetic mechanisms and their implications in human health.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Jeremy Nichols and Renee Ann Reijo Pera, who have contributed to her research endeavors.

Conclusion

Birgitt Schüle's innovative work in genetic research continues to impact the scientific community and offers promising avenues for future studies in human health and disease. Her patents reflect her dedication to advancing biotechnology and improving our understanding of complex genetic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…